April 6, 2022
PENTICTON, BC / ACCESSWIRE / April 6, 2022 / EastWest Bioscience Inc. (“EastWest” or “Company”) (TSXV:EAST), announced that it has filed its Quarterly Financials and MD&A […]
March 23, 2022
PENTICTON, BC / ACCESSWIRE / March 23, 2022 / EastWest Bioscience Inc. (“EastWest” or “Company”) (TSXV:EAST), reports that, pursuant to the Board of Directors Ancillary Compensation Agreement […]
November 25, 2021
VANCOUVER, BC / ACCESSWIRE / November 24, 2021 / EastWest Bioscience Inc. (the “Company” or “EastWest“) (TSXV:EAST) announces the issuance of 3,095,044 common shares at a price of CDN […]
November 17, 2021
PENTICTON, BC / ACCESSWIRE / November 17, 2021 / EastWest Bioscience Inc. (“EastWest” or “Company”) (TSXV:EAST), reports that it has closed a non-brokered financing round (the “Offering”) […]
November 5, 2021
VANCOUVER, BC / ACCESSWIRE / November 5, 2021 / EastWest Bioscience Inc. (the “Company” or “EastWest“) (TSXV:EAST) announces the proposed issuance of 3,095,044 common shares at a price of […]
November 2, 2021
EastWest Bioscience Announces Grant of Stock Options and Cancellation of Certain Other Stock Options
VANCOUVER, BC / ACCESSWIRE / November 2, 2021 / EastWest Bioscience Inc. (the “Company” or “EastWest“) (TSXV:EAST) announces the grant of 2,230,000 stock options to certain directors, […]
September 28, 2021
PENTICTON, BC / ACCESSWIRE / September 24, 2021 / EastWest Bioscience Inc. (“EastWest” or “Company”) (TSXV:EAST), reports that its self-storage focused subsidiary, 1290185 B.C. LTD, (“185”), has […]
September 3, 2021
PENTICTON, BC / ACCESSWIRE / September 3, 2021 / EastWest Bioscience Inc. (“EastWest” or “Company”) (TSXV:EAST), reports that it is adding self-storage to its already diverse […]